Enact Holdings Q4 revenue misses estimates

Reuters
02/04
Enact Holdings Q4 revenue misses estimates

Overview

  • U.S. mortgage insurer's Q4 revenue missed analyst expectations

  • Adjusted operating income per share for Q4 beat analyst estimates

  • Company returned over $500 mln to shareholders in 2025

Outlook

  • Company announces new share repurchase program of up to $500 mln

  • Enact sees continued affordability pressures and interest rate volatility shaping housing activity

Result Drivers

  • INSURANCE IN-FORCE - Primary insurance in-force increased 2% year-over-year to $273 bln

  • LOSS RESERVE RELEASE - Losses incurred decreased due to a $60 mln net reserve release reflecting favorable cure performance

  • OPERATING EXPENSES - Sequential increase in operating expenses driven by incentive-based compensation

Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

Q4 Revenue

Miss

$312.71 mln

$316.78 mln (3 Analysts)

Q4 Adj. Diluted Operating Income per share

Beat

$1.23

$1.09 (4 Analysts)

Q4 EPS

$1.22

Q4 Net Income

$177 mln

Q4 Adjusted Operating Income

$179 mln

Q4 Expense Ratio

24.00%

Q4 ROE

13.30%

Analyst Coverage

  • The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 1 "strong buy" or "buy", 4 "hold" and no "sell" or "strong sell"

  • The average consensus recommendation for the property & casualty insurance peer group is "buy."

  • Wall Street's median 12-month price target for Enact Holdings Inc is $42.50, about 5.1% above its February 2 closing price of $40.45

  • The stock recently traded at 9 times the next 12-month earnings vs. a P/E of 8 three months ago

Press Release: ID:nGNX6pHqY4

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

应版权方要求,你需要登录查看该内容

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10